Cart
sales@molnova.com
VPC-80051 racemate
CAS No. 877969-69-2
VPC-80051 racemate ( VPC-80051 )
Catalog No. M28584 CAS No. 877969-69-2
VPC-80051 is the first small molecule inhibitor of hnRNP A1 splicing activity by using a computer-aided drug discovery approach.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 87 | Get Quote |
|
| 5MG | 147 | Get Quote |
|
| 10MG | 250 | Get Quote |
|
| 25MG | 537 | Get Quote |
|
| 50MG | 767 | Get Quote |
|
| 100MG | 1053 | Get Quote |
|
| 500MG | 2115 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVPC-80051 racemate
-
NoteResearch use only, not for human use.
-
Brief DescriptionVPC-80051 is the first small molecule inhibitor of hnRNP A1 splicing activity by using a computer-aided drug discovery approach.
-
DescriptionVPC-80051 is the first small molecule inhibitor of hnRNP A1 splicing activity by using a computer-aided drug discovery approach.(In Vitro):VPC-80051 interacts directly with hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line.
-
SynonymsVPC-80051
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number877969-69-2
-
Formula Weight301.3
-
Molecular FormulaC16H13F2N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(c(cc1)cc(F)c1F)NC(c1n[nH]c2c1cccc2)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fan X, Xu NJ, Shi JG. Bromophenols from the red alga Rhodomela confervoides. J Nat Prod. 2003 Mar;66(3):455-8.
molnova catalog
related products
-
CCF0058981
CCF0058981 is a SARS-CoV-2 inhibitor with low nanomolar biochemical inhibition and efficacy in cellular models comparable to that of Remdesivir.
-
Eprazinone dihydroch...
Eprazinone 2hydrochloride is a drug with proposed mucolytic, secretolytic, and bronchial antispasmodic properties.
-
8-Prenylkaempferol
8-Prenylkaempferol is an effective agent for attenuating pro-inflammatory NO induction, it may be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-κB and IRF-3 and in part by interfering with IκB degradation which subsequently decreases NF-κB translocation.
